| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| S R Marde. Clinical experience with risperidone. The Journal of clinical psychiatry. vol 57 Suppl 9. 1996-10-24. PMID:8823352. |
the controlled trials indicate that risperidone is an effective anti-psychotic that may have advantages over conventional antipsychotics for treating both positive and negative symptoms of schizophrenia. |
1996-10-24 |
2023-08-12 |
Not clear |
| J P Warner, J A Gledhill, A Wakelin. The use of risperidone in treatment-resistant schizophrenia: two case reports. International clinical psychopharmacology. vol 11. issue 1. 1996-10-10. PMID:8732318. |
the use of risperidone in treatment-resistant schizophrenia: two case reports. |
1996-10-10 |
2023-08-12 |
Not clear |
| J P Warner, J A Gledhill, A Wakelin. The use of risperidone in treatment-resistant schizophrenia: two case reports. International clinical psychopharmacology. vol 11. issue 1. 1996-10-10. PMID:8732318. |
the role of risperidone in the management of treatment-resistant schizophrenia remains unclear. |
1996-10-10 |
2023-08-12 |
Not clear |
| J P Warner, J A Gledhill, A Wakelin. The use of risperidone in treatment-resistant schizophrenia: two case reports. International clinical psychopharmacology. vol 11. issue 1. 1996-10-10. PMID:8732318. |
we describe two patients with treatment-resistant schizophrenia characterized by unremitting delusions, thought disorder and self-neglect who had a sustained improvement in their symptoms soon after starting risperidone. |
1996-10-10 |
2023-08-12 |
Not clear |
| J Carman, J Peuskens, A Vangeneugde. Risperidone in the treatment of negative symptoms of schizophrenia: a meta-analysis. International clinical psychopharmacology. vol 10. issue 4. 1996-09-26. PMID:8748041. |
risperidone in the treatment of negative symptoms of schizophrenia: a meta-analysis. |
1996-09-26 |
2023-08-12 |
Not clear |
| J Carman, J Peuskens, A Vangeneugde. Risperidone in the treatment of negative symptoms of schizophrenia: a meta-analysis. International clinical psychopharmacology. vol 10. issue 4. 1996-09-26. PMID:8748041. |
risperidone has antiserotonergic and antidopaminergic properties that may make it more effective than conventional antipsychotic agents in the treatment of the negative symptoms of schizophrenia. |
1996-09-26 |
2023-08-12 |
Not clear |
| D Umbricht, J M Kan. Risperidone: efficacy and safety. Schizophrenia bulletin. vol 21. issue 4. 1996-09-26. PMID:8749887. |
this article reviews the evidence for the efficacy and effectiveness of risperidone in persons with schizophrenia. |
1996-09-26 |
2023-08-12 |
Not clear |
| D Umbricht, J M Kan. Risperidone: efficacy and safety. Schizophrenia bulletin. vol 21. issue 4. 1996-09-26. PMID:8749887. |
risperidone's antipsychotic efficacy is shown to be consistently superior to that of placebo and at least comparable to that of haloperidol and perphenazine for patients in the acute phase of schizophrenia. |
1996-09-26 |
2023-08-12 |
Not clear |
| S Bazir. Risperidone in schizophrenia. The British journal of psychiatry : the journal of mental science. vol 168. issue 1. 1996-09-26. PMID:8770444. |
risperidone in schizophrenia. |
1996-09-26 |
2023-08-12 |
Not clear |
| A Schotte, P Bonaventure, P F Janssen, J E Leyse. In vitro receptor binding and in vivo receptor occupancy in rat and guinea pig brain: risperidone compared with antipsychotics hitherto used. Japanese journal of pharmacology. vol 69. issue 4. 1996-09-26. PMID:8786644. |
the predominant 5-ht2a-receptor occupancy most likely underlies risperidone's beneficial effects on the negative symptoms of schizophrenia and an adequately low d2-receptor occupancy adds to the treatment of positive symptoms with a low liability of eps. |
1996-09-26 |
2023-08-12 |
human |
| M Tohen, C A Zarate, F Centorrino, J I Hegarty, M Froeschl, S B Zarat. Risperidone in the treatment of mania. The Journal of clinical psychiatry. vol 57. issue 6. 1996-08-05. PMID:8666562. |
risperidone, a 5-ht2 and d2 antagonist, has been shown to be an effective antipsychotic in the treatment of schizophrenia but has unclear efficacy in the treatment of psychotic affective disorders. |
1996-08-05 |
2023-08-12 |
Not clear |
| L C Kopala, D Fredrikson, K P Good, W G Hone. Symptoms in neuroleptic-naive, first-episode schizophrenia: response to risperidone. Biological psychiatry. vol 39. issue 4. 1996-07-19. PMID:8645777. |
symptoms in neuroleptic-naive, first-episode schizophrenia: response to risperidone. |
1996-07-19 |
2023-08-12 |
Not clear |
| D G Daniel, T E Goldberg, D R Weinberger, J E Kleinman, D Pickar, L J Lubick, T S William. Different side effect profiles of risperidone and clozapine in 20 outpatients with schizophrenia or schizoaffective disorder: a pilot study. The American journal of psychiatry. vol 153. issue 3. 1996-05-24. PMID:8610833. |
different side effect profiles of risperidone and clozapine in 20 outpatients with schizophrenia or schizoaffective disorder: a pilot study. |
1996-05-24 |
2023-08-12 |
Not clear |
| S Kapur, G Remingto. Serotonin-dopamine interaction and its relevance to schizophrenia. The American journal of psychiatry. vol 153. issue 4. 1996-04-24. PMID:8599393. |
the therapeutic success of clozapine and risperidone has focused attention on the interaction between serotonin and dopamine systems as an avenue for superior therapeutics in schizophrenia. |
1996-04-24 |
2023-08-12 |
Not clear |
| P Landr. Effect of risperidone on polydipsia and hyponatremia in schizophrenia. Canadian journal of psychiatry. Revue canadienne de psychiatrie. vol 40. issue 9. 1996-03-13. PMID:8574992. |
effect of risperidone on polydipsia and hyponatremia in schizophrenia. |
1996-03-13 |
2023-08-12 |
Not clear |
| P Czobor, J Volavka, R C Meibac. Effect of risperidone on hostility in schizophrenia. Journal of clinical psychopharmacology. vol 15. issue 4. 1995-12-19. PMID:7593706. |
effect of risperidone on hostility in schizophrenia. |
1995-12-19 |
2023-08-12 |
Not clear |
| E Lindström, B Eriksson, A Hellgren, L von Knorring, G Eberhar. Efficacy and safety of risperidone in the long-term treatment of patients with schizophrenia. Clinical therapeutics. vol 17. issue 3. 1995-12-04. PMID:7585844. |
efficacy and safety of risperidone in the long-term treatment of patients with schizophrenia. |
1995-12-04 |
2023-08-12 |
Not clear |
| E Lindström, B Eriksson, A Hellgren, L von Knorring, G Eberhar. Efficacy and safety of risperidone in the long-term treatment of patients with schizophrenia. Clinical therapeutics. vol 17. issue 3. 1995-12-04. PMID:7585844. |
the long-term efficacy and safety of risperidone were evaluated in patients with chronic schizophrenia in an open-label study. |
1995-12-04 |
2023-08-12 |
Not clear |
| H Quintana, M Keshava. Case study: risperidone in children and adolescents with schizophrenia. Journal of the American Academy of Child and Adolescent Psychiatry. vol 34. issue 10. 1995-12-01. PMID:7592266. |
case study: risperidone in children and adolescents with schizophrenia. |
1995-12-01 |
2023-08-12 |
Not clear |
| P E Keck, D R Wilson, S M Strakowski, S L McElroy, D L Kizer, T M Balistreri, H M Holtman, M DePries. Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders. The Journal of clinical psychiatry. vol 56. issue 10. 1995-11-08. PMID:7559373. |
however, little is known about the efficacy of risperidone in patients with schizophrenia refractory to treatment with typical antipsychotics, schizoaffective disorder, and psychotic mood disorders. |
1995-11-08 |
2023-08-12 |
Not clear |